| JPMORGAN stuft STMicro auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für STMicroelectronics mit einem Kursziel von 24 Euro auf "Neutral" belassen. Analyst Sandeep Deshpande favorisiert in seinem Ausblick... ► Artikel lesen |
| STMicroelectronics N.V.: STMicroelectronics' new GaN ICs platform for motion control boosts appliance energy ratings | STMicroelectronics' new GaN ICs platform for motion control boosts appliance energy ratings High-efficiency GaN power integrated technology tailored for motor drives in white goods and factory automation... ► Artikel lesen |
| AKTIEN IM FOKUS: Europäische Chipwerte nach Nvidia-Schwankungen unter Druck | FRANKFURT/NEW YORK (dpa-AFX) - Der Vortagskursrutsch im New Yorker Handel wirkt am Freitag im europäischen Technologiesektor nach. Nachdem der von Tech-Werten geprägte US-Leitindex Nasdaq 100 am Donnerstag... ► Artikel lesen |
| VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer | SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults | Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need
INO-3107 previously received... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement Plan | PLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help... ► Artikel lesen |